NOVARTIS AG (NVSEF)

Clinical trial NCT06004661 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-17 → 2026-12-14 3. primary completion date: 2026-06-17 → 2026-12-14 4. enrollment: 20 → 23 participants 5. enrollment type: ESTIMATED → ACTUAL

ASTRAZENECA PLC (AZN)

Clinical trial NCT06951880 updates: 1. start date: 2025-06-27 → 2026-07-23 2. completion date: 2026-09-24 → 2027-10-25 3. primary completion date: 2026-09-24 → 2027-10-25 4. enrollment: 178 → 160 participants